Objective-We investigated the influence of genetic variants (rare and common) in the gene encoding periostin (POSTN) on atherosclerosis as measured in arterial specimens from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
R ecent genome-wide association studies (GWAS) of cardiovascular disease (CVD) phenotypes have focused on the identification of the relatively common genetic variants that are included in the large genome-wide hybridization arrays used for these purposes. [1] [2] [3] However, CVD susceptibility likely involves genetic variants over a wide range of allelic frequencies, including relatively rare variants that may have moderate to large phenotypic effects. Contemporary cardiovascular GWAS are also challenged by the extensive heterogeneity within clinical classifications because of multiple pathophysiological processes that culminate in the same CVD end points (ie, myocardial infarction). In this study, we have addressed these major issues in a comprehensive examination of the full frequency spectrum of allelic variation in POSTN, a strong CVD candidate gene that encodes the extracellular matrix protein periostin. To reduce effects of heterogeneity in CVD end points, we tested for associations of POSTN variants with atherosclerosis as directly measured in the autopsy study Pathobiological Determinants of Atherosclerosis in Youth (PDAY). 4 Previous functional studies have focused on periostin as a major transforming growth factor-␤-responsive component of cardiac healing (stimulates cardiomyocyte regeneration and angiogenesis), 5 aortic valve development and degeneration (tissue remodeling, angiogenesis), 6 and response to vascular injury (promotes smooth muscle cell proliferation, migration, and differentiation). 7 Knockout mice for periostin (periostin Ϫ/Ϫ mice) showed impaired cardiac healing after acute myocardial infarction that resulted in cardiac rupture. 8 Periostin may also be involved in atherosclerosis because many of these cellular processes are also involved in development of arterial lesions. Of particular interest are the recent findings of direct tissue proteomic analyses that periostin is among a limited group of proteins that are highly expressed in coro-nary atherosclerotic plaques. 9 The initial findings by mass spectrometry were validated by immunohistochemical studies that localized periostin in advanced coronary atherosclerotic lesions.
POSTN consists of 23 exons that span approximately 36 kb on human chromosome 13q. A recent GWAS of PDAY subjects found associations of POSTN with atherosclerosis using a case/control design (unpublished data from the SNPs and Extent of Atherosclerosis [SEA] multicenter study, 2011). The POSTN single-nucleotide polymorphism (SNP) with the strongest association (rs9576312) ranked 14th among the top hits of the SEA GWAS. The current study provides a comprehensive survey of 87 common POSTN SNPs for associations with multiple measures of atherosclerosis in 2527 PDAY subjects. These POSTN SNPs cover the entire locus, including exons, introns, and 5Ј and 3Ј flanking regions. In addition, we resequenced POSTN functional regions (promoter, exons, splice junctions) in PDAY cases/ controls to assess the contribution of rare variants in POSTN to associations with atherosclerosis in young persons.
Methods

Study Subjects
Association studies of common POSTN variants used PDAY subjects (total nϭ2527) composed of African American (AA) (nϭ1326) and European American (EA) (nϭ1201) males and females for which DNA samples and arterial lesion measurements were available ( Table 1 ). The PDAY subjects were 15 to 34 years of age who died of non-CVD related causes (accidents, homicides, or suicides). 4 The purpose of the PDAY project was to evaluate early development of atherosclerosis, so subjects with congenital heart disease, AIDS, and hepatitis were excluded. For POSTN resequencing, PDAY cases (nϭ291) were selected with the highest total raised lesion scores, defined by summing the percentage of surface involvement in raised lesions from the thoracic aorta, abdominal aorta, and coronary arteries, with adjustment by age, age-squared, race, and gender (same subjects used for SEA GWAS) ( Table 2 ). The PDAY control group (nϭ294) was selected from subjects with no raised lesions, with frequency matching for age, race, and gender (a subset of the 600 controls for the SEA GWAS).
Arterial Measurements
Arterial specimens were removed at autopsy and treated with Sudan IV, which stains lipids on the arterial surface (right coronary and left half of the aorta). The percentage of involvement of arterial surfaces with fatty streaks and raised lesions was estimated by averaging of values determined independently by 3 pathologists. 4
POSTN Genotyping and Resequencing
To provide thorough coverage of POSTN for association studies, we selected 86 SNPs from HapMap and 1 nonsynonymous substitution for genotyping in 2527 PDAY subjects. HapMap SNPs were not limited to tagging SNPs because of the complex linkage disequilibrium in the POSTN genomic region. Instead, we genotyped all HapMap SNPs from the CEU and YRI populations that were suitable for the SNPlex assay. We used the high-throughput SNPlex platform (Applied Biosystems) for multiplexed genotyping of hepatic genomic DNA samples with the ABI 3730xl DNA Analyzer.
Resequencing of POSTN functional regions (promoter, exons, splice junctions) in PDAY cases/controls (total nϭ585) used the BMI indicates body mass index; TF, thoracic aorta fatty streaks; TR, thoracic aorta raised lesions; AF, abdominal aorta fatty streaks; AR, abdominal aorta raised lesions; CF, coronary artery fatty streaks; CR, coronary artery raised lesions.
VariantSEQr platform (Applied Biosystems), which allows amplification of exons with similar polymerase chain reaction conditions, as well as sequencing of amplicons (average 500 bp) with a single universal primer. POSTN regions that were not covered by Vari-antSEQr primers were amplified with custom designed primers (Lasergene 7.0, DNASTAR), and sequenced with internal primers. Amplicons were sequenced on both strands using the automated ABI Prism 3730xl DNA Analyzer (96-capillary array) and commercially available reagents (BigDye Terminator cycle sequencing kits, ABI). Sequence traces were used for automated sequence assembly, alignment, and variant calling (Lasergene 7.0). We identified 69 variants that were verified by manual inspection of sequence traces, including 46 novel variants that were not found in NCBI database for Single Nucleotide Polymorphisms.
Statistical Analyses
Allele frequencies for POSTN variants were calculated by allele counting, and the Fisher exact test was used to evaluate SNP genotypes for departures from Hardy-Weinberg equilibrium. SNPs with minor allele frequency (MAF) Ͻ0.05 or Hardy-Weinberg equilibrium probability value Ͻ0.001 were excluded from the analysis, resulting in 76 SNPs for EA and 72 SNPs for AA that were used for subsequent analyses. Correlations among POSTN SNPs were estimated using LDSelect (r 2 Ͼ0.8). 10 SNP association analyses used linear regression for lesion traits, including percentage of involvement in abdominal fatty streaks and thoracic fatty streaks after square root transformation. We used binary transformed variables (zero versus nonzero values) for logistic regression for lesion traits that were not detectable in a large proportion of PDAY subjects, including abdominal raised lesions, thoracic raised lesions, coronary artery fatty streaks, and coronary artery raised lesions. All analyses were performed separately for AA and EA, and included adjustment for covariates that were associated with lesion traits (age, gender, and body mass index). All SNPs were coded additively for the minor allele, and all analyses were performed using the Statistical Analysis System programming language (SAS 9.1, SAS Institute, Cary, NC). False discovery rate was used to correct for the multiple testing. 11 For variants from POSTN resequencing, we used paired t tests to assess differences in quantitative lesion traits between cases and controls. For rare variant analysis, we used the weighted-sum method for all POSTN variants identified by resequencing. 12 We estimated significance values by permutation (1000ϫ) according to Madsen and Browning. 12 Results Table 1 shows characteristics of the PDAY study subjects (nϭ2527), including mean values for percentage of arterial surfaces involved in lesions (fatty streaks and raised lesions in abdominal, thoracic, and coronary arteries). Consistent with the study design to characterize development of atherosclerosis in young persons, the mean age of the PDAY subjects was 24 to 25 years of age. 4 To evaluate the influence of POSTN variability on atherosclerosis, we selected 87 SNPs, including HapMap SNPs and 1 potential functional SNP, for genotyping in the PDAY subjects. Supplemental  Table I (available online at http://atvb.ahajournals.org) shows the identity, location, gene region, and minor allele frequencies (MAF) of the SNPs separately for AA and EA groups.
We tested the POSTN SNPs for associations with percentage of involvement in fatty streaks and raised lesions. Figure  1 shows the significance values for associations separately for AA and EA groups (dotted horizontal line at Pϭ0.01). The strongest associations were with percentage of involvement with raised lesions in abdominal aorta (AA and EA) and with fatty streaks in thoracic aorta (EA). Table 3 shows a list of all POSTN SNPs that reached significance (PϽ0.01) for abdominal raised lesions and thoracic fatty streaks. No SNPs reached significance (PϽ0.01) for the other lesion traits ( Figure 1 ). Some SNPs that showed significance at PϽ0.01 in one race also showed suggestive evidence in the other race (PϽ0.05) for a particular lesion trait (Table 3 ). Such SNPs represent associations that show consistency in both races. For example, rs11618172 was significantly associated with abdominal aorta raised lesions in EA (Pϭ0.0014) and also showed suggestive evidence for association in AA (Pϭ0.0346). We calculated false discovery rates to correct for multiple testing in association analyses. 11 For EA, we identified 23 significant tests (PϽ0.01) with a false discovery rate indicating that less than 1 of the 23 is expected by chance (false positive). For AA, we identified 13 significant tests (PϽ0.01), 1 of which may be a false positive. We determined correlation patterns among POSTN SNPs for AA and EA groups. 10 Interestingly, we found that the SNPs that showed significant associations (PϽ0.01) were found in only a few correlation bins (Table 3 ). Figure 2 shows the correlation bins that contain associated SNPs in AA (bin 1) and EA (bins 2 and 5). These bins result from complex patterns of linkage disequilibrium (LD) across this 60-kb region on chromosome 13. Supplemental Figures I and II present the pairwise LD maps for the POSTN SNPs separately for AA and EA. The POSTN SNPs in strong LD are not contiguous and are not arrayed in discrete patterns that resemble standard haplotype blocks. Instead, we observed long-range correlations among SNPs that spanned the entire region.
A major motivation for the current study was the results of GWAS for PDAY cases/controls that identified associations with variation spanning POSTN (unpublished data from the SEA multicenter project). The current study used the same PDAY cases/controls as the SEA GWAS (291 cases, 296 of the 600 GWAS controls). The SEA GWAS tested 4 SNPs for POSTN: rs3923854 (intron 2, Pϭ1.8ϫ10 Ϫ4 ), rs9576312 (intron 3, Pϭ1.8ϫ10 Ϫ5 ), rs7986347 (intron 11, Pϭ4.3ϫ10 Ϫ5 ), and rs4512969 (intron 16, Pϭ6.7ϫ10 Ϫ2 ). The POSTN SNP with the strongest association (rs9576312) ranked 14th among the top hits of the SEA GWAS. Three of these SNPs were included in our comprehensive SNP survey (nϭ2572). We found suggestive evidence for association of rs7986347 with thoracic fatty streaks (Pϭ0.024) and abdominal aorta raised lesions (Pϭ0.041) in EA. In addition, we found evidence for association of rs7986347 in the resequenced case/controls (Pϭ0.029 in AA, Pϭ0.055 in EA). For rs4512969, we found associations with thoracic fatty streaks (Pϭ0.044) and abdominal aorta raised lesions (0.018) in EA. For rs3923854, we found associations with thoracic fatty streaks (Pϭ0.007) and abdominal aorta raised lesions (0.016) in EA (Table 3 ).
In addition to our association studies of common SNPs, we examined the effects of rare variants by resequencing putative POSTN functional regions (promoter region, exons, intron splice junctions) in selected groups of PDAY subjects ( Table  2 ). The case group consisted of PDAY subjects with the largest amounts of raised lesions (nϭ291), and the matched control group had no raised lesions (nϭ294). Supplemental  Table II shows key characteristics of the 69 POSTN variants identified by resequencing including identity, location, and MAF separately for cases and controls in AA and EA. The POSTN sequenced variants spanned the range of allele frequencies from rare (MAF Ͻ0.01) to common (MAF Ն0.01) variants. Of the 69 POSTN variants, we found 33 novel variants, including 12 that were also found in the 1000 Genomes database. We used the weighted-sum method, which jointly tests all of the SNPs for groupwise association with a weighting system based on allele frequencies to reduce the influence of common variants. 12 However, we did not find significant associations for the POSTN sequenced variants in either AA (Pϭ0.3081) or EA (Pϭ0.2794). Six of the variants from resequencing in case/controls also showed significant associations in the SNP survey in the larger PDAY cohort (rs1028728, rs1006416, rs17256386, rs7323378, rs7322993, rs4390468) ( Table 3 ). In general, these variants did not reach statistical significance (PϽ0.01) in the case/control analyses, likely because of a much smaller sample size, as well as differences in lesion phenotypes (Supplemental Table II ). The cases and controls were defined by the sum of raised lesions across all arteries, whereas the SNP study used quantitative measures for each artery. However, the direction of phenotypic effects was the same for the 2 analyses of these 6 variants.
Discussion
This comprehensive survey of POSTN variation provides clear evidence of associations with development of atherosclerosis in young persons from the PDAY study. Our results provide strong support for the involvement of periostin in atherosclerosis, particularly combined with previous proteomic analysis that identified periostin as 1 of a limited number of proteins that are abundant in atherosclerotic lesions. 9 Analyses of large numbers of common POSTN variants identified associations with fatty streaks and raised lesions for a few correlation bins of SNPs that span the entire locus in both AA and EA groups ( Table 3 and Figure 2 ). Deep resequencing of POSTN in selected PDAY subjects identified rare variants throughout POSTN in different functional regions ( Supplemental Table II ).
Although the results of this SNP survey clearly demonstrate the involvement of POSTN variability in atherosclerosis, complex patterns of long-range LD across the locus obscure identification of the causative variant(s) that may be embedded in the groups of associated SNPs (Figure 2 and Supplemental Figures I and II) . Alternatively, multiple variants may have functional properties that act together to influence lesion development. Interestingly, the largest correlation bins in EA (bins 2 and 5) have different patterns of associations with lesions. Every SNP in bin 2 shows associations only with fatty streaks in thoracic aorta in EA. In contrast, every SNP in bin 5 shows association (PϽ0.05) with both thoracic aorta fatty streaks and raised lesions in abdominal aorta ( Table 3 ). For example, AA homozygotes for rs7336560 in bin 5 have a mean involvement of 17.98% for fatty streaks in thoracic artery (nϭ258), compared with AC heterozygotes, with 18.37% involvement (nϭ561), and CC homozygotes, with 20.68% involvement (nϭ362). Similarly, AA homozygotes have a mean involvement of 2.37% for raised lesions in abdominal artery, compared with AC heterozygotes, with 3.15% involvement, and CC homozygotes, with 4.03% involvement.
Many of the associated variants occur in the 5Ј flanking region and may influence regulation of POSTN expression. For example, SNP rs17197936 (position Ϫ2976) that is associated with extent of raised lesions in abdominal aorta in EA (Pϭ0.0074) occurs in a functionally defined enhancer region (37 bp) in the POSTN proximal promoter region. Unlike the other associated SNPs, rs17197936 is not correlated with other POSTN SNPs, comprising a single LDSelect bin (bin 11). Lindsley et al used in vitro transcription assays to determine that this enhancer element was essential for POSTN promoter activities. 13 Within the enhancer element, rs17197936 alters an evolutionarily conserved binding site for the AP-1 transcription factor that could potentially affect POSTN expression (AATGACTTA3 AATGACTTG). Another SNP in the proximal promoter region (rs1028728, position Ϫ953) that is associated with fatty streaks in thoracic aorta in EA (Pϭ0.0043) was associated with early onset breast cancer in Polish women (odds ratio 1.61, Pϭ0.03). 14 In that study, POSTN was chosen for association studies because of periostin's role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF) expression. None of the 3 known nonsynonymous SNPs in the survey were associated with arterial lesion measures.
Statistical analysis of the sequenced variants (291 cases, 294 controls) with a weighting system to reduce the influence of common variants did not yield evidence of the influence of rare POSTN variants on atherosclerosis in young persons. 12 These results may be interpreted as showing that POSTN does not contain rare variants that significantly influence arterial lesions in young persons. Alternatively, the lack of association may be due to insufficient statistical power or to the resequenced cases not representing sufficiently extreme vascular phenotypes, because PDAY was designed to characterize development of atherosclerosis in normal individuals (subjects with CVD were excluded). The rare variants oc- Correlation bins for POSTN SNPs that showed associations (PϽ0.01) with extent of arterial lesions in AA and EA groups. Correlation bins for EA are presented below the POSTN gene map (exons indicated by blocks), and the bin for AA is shown above the map. The correlation bins are shown as horizontal lines with dots for each associated SNP in the bin. curred in different functional regions of POSTN, including 7 nonsynonymous SNPs in the coding region (Supplemental Table II ). Three of the rare nonsynonymous SNPs were found in the control group (Asp293Glu, Ala484Val, Thr763Pro) and 4 in the cases with arterial raised lesions (Leu46Phe, Arg228His, Val666Met, Phe799Ser). We found no apparent functional differences for amino acid substitutions in cases versus controls, with Polyphen-2 scores throughout the range in both groups (0 [least damaging] to 1 [most damaging]). 15 In general, the wild-type amino acids were highly conserved at the sites of these rare substitutions in chordates. One exception is Val666Met, where either amino acid can be found among mammalian species. We did not find any nonsense substitutions that would introduce premature stop codons with obvious functional effects on periostin production.
Periostin genetic variation could influence atherosclerosis via many possible pathways because recent studies have shown that this secreted extracellular matrix protein is involved in multiple atherogenic processes. Periostin expression and secretion is induced by transforming growth factor-␤ in many of the cell types that participate in lesion development, including endothelial cells, smooth muscle cells, and myofibroblasts. For example, periostin has been shown to stimulate endothelial cell migration and tube formation for angiogenesis, an important process in lesion development. 6 The same study found that aortic valve thickening in mice fed high-fat diets was associated with increased periostin production that stimulates expression of matrix metalloproteinases, enzymes involved in atherosclerosis and vascular remodeling. 6 Periostin secreted by cardiac fibroblasts plays a central role in cardiac wound healing by promotion of cardiomyocyte regeneration and proliferation via ␣ v ␤ integrin and focal adhesion kinase signaling pathways. 5, 16 Expression profiling in a primate model of aortic grafting found that POSTN was 1 of only 13 genes induced in vascular neointimal smooth muscle cells. 17 In addition, recent studies have shown that periostin is highly expressed in neointimal smooth muscle cells and adventitial myofibroblasts in response to balloon injury of rat carotid arteries. 7 On vascular injury, secreted periostin acts to stimulate smooth muscle cell migration, differentiation, and collagen deposition as a central component in fibrosis.
Periostin's precise role(s) in development of atherosclerosis is not yet clear. However, proteomic analysis using mass spectrometry found that 90% of analyzed lesions contain periostin. 9 Supporting immunohistochemical studies localized periostin in the intima, preatheroma regions, and extracellular matrix of advanced lesions with calcification. 9 Although most previous studies have focused on periostin in cardiac and valvular development and disease, our results showing that POSTN variants are associated with extent of atherosclerosis in young persons provide additional evidence of the importance of periostin in development of atherosclerosis in the arterial wall.
In conclusion, a comprehensive SNP survey of POSTN variation (87 SNPs) identified associations with quantitative atherosclerotic lesion traits as directly measured in arterial samples from subjects of the multicenter PDAY autopsy study (nϭ2527). The associated SNPs comprised only a few correlation bins that span the entire POSTN locus. The POSTN associations in the SEA GWAS were confirmed in the current study and extended with large numbers of SNPs that showed consistent associations with arterial lesions. Resequencing POSTN functional regions in PDAY cases with raised lesions (nϭ291) and controls with no raised lesions (nϭ294) found numerous new variants, including 7 nonsynonymous variants (4 in the cases, and 3 in the controls). However, statistical analysis of the sequenced variants with a weighting system to reduce the influence of common variants did not identify significant associations with rare variants. Overall, the SEA GWAS and this targeted study suggest that relatively common variants in POSTN, rather than rare variants, influence the development of atherosclerosis in young persons.
